FIELD: medicine. SUBSTANCE: method involves administering a number of transendoscopical injections around ulcer using Splenoid preparation. The preparation is diluted in 10 ml of 0.25% novocaine or physiological salt solution in the amount of 115-230 mg and injected into 2-3 points on the ulcer defect boundary into submucous layer. The treatment is applied on the background of traditional anti-ulcer treatment including preparation for H2-blocking histamine and anti-Helicobacter preparations. Procedures of making injections are carried out with 2-3 long pause. The number of procedures is 4-6. EFFECT: enhanced effectiveness of treatment; accelerated cicatrization process. 5 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ENDOSCOPIC BIOPLASTY OF GASTRODUODENAL ULCERS WITH COMPLEX BIOPLASTIC MATERIAL | 2013 |
|
RU2520599C1 |
| METHOD FOR SELECTING DUODENAL PEPTIC ULCER TREATMENT TYPE | 2003 |
|
RU2252709C1 |
| METHOD OF TREATING RECURRENCE OF GASTRODUODENAL ULCERS BY TRANSENDOSCOPIC ADMINISTRATION OF LYSOZYME WITH MOLECULAR IODINE | 1998 |
|
RU2172181C2 |
| ANTI-ULCER MEDICAMENT AND METHOD FOR TREATING GASTRIC AND DUODENAL PEPTIC ULCER DISEASE | 2000 |
|
RU2183458C2 |
| METHOD OF DUODENUM ULCER DISEASE TREATMENT | 1993 |
|
RU2082413C1 |
| THERAPY METHOD FOR SLUGGISH ULCERS AND EROSIONS IN GASTRODUODENAL SYSTEM | 2003 |
|
RU2261091C2 |
| METHOD FOR TREATING ULCEROUS GASTRIC AND DUODENAL DISEASE | 1999 |
|
RU2189215C2 |
| METHOD FOR TREATMENT OF PATIENT WITH ULCEROUS DISEASES COMBINED WITH DIABETES MELLITUS | 2004 |
|
RU2278676C1 |
| METHOD OF TREATMENT OF PATIENTS WITH DUODENUM ULCER DISEASE OF MODERATE SEVERITY | 2000 |
|
RU2173991C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING GASTRODUODENAL ULCER, POSSESSING IMMUNOMODULATORY, ANTIVIRAL, ANTIBACTERIAL, ANTI-INFLAMMATORY, ANTIOXIDANT AND REGENERATIVE EFFECT IN FORM OF TABLETS, CAPSULES OR GEL | 2013 |
|
RU2538697C1 |
